Emmanouil Andreou

Mr. Emmanouil Andreou


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EKEmmanuel Kontomanolis
Emmanuel Kontomanolis
IPIoannis Prokopakis
Ioannis Prokopakis
AKAntonios Koutras
Antonios Koutras
EAEmmanouil Andreou
Emmanouil Andreou
DMDionysios Metaxas
Dionysios Metaxas
PPParaskevas Perros
Paraskevas Perros
Background: Pregnancy-Related Acute kidney injury (PRAKI) is a critical complication of pregnancy, defined by the sudden deterioration in renal function during gestation or within the initial six weeks postpartum. Pregnancy is thought to increase the risk of acute kidney injury (AKI) by 51%. This is linked to the anatomical alterations that occur during pregnancy and special conditions, such as preeclampsia/eclampsia. PRAKI’s epidemiology and outcome vary between developed and developing nations. PRAKI is an uncommon entity in high-income countries; however, its incidence has recently increased. The aim of this systematic review is to evaluate the maternal and perinatal outcomes and risk factors affecting pregnancies affected by AKI. Methods: Comprehensive research was performed in PubMed/Medline, Scopus, and Google Scholar electronic databases from 2015 up to January 2025, using the terms AKI, PRAKI, sepsis, preeclampsia/eclampsia, liver enzymes, low platelet count (HELLP) syndrome, and pregnancy. After a thorough assessment, 25 full-text articles were obtained. Results: Our results revealed that preeclampsia, eclampsia, HELLP syndrome, and antepartum and postpartum hemorrhage predispose women to PRAKI. Other unusual factors, like disseminated intravascular coagulation (DIC) or hemolytic uremic syndrome (HUS), should not be underestimated. Furthermore, the latest published data showed unfavorable maternal and fetal outcomes in pregnancies affected by AKI compared to the general population. Conclusions: PRAKI constitutes a serious pregnancy complication that requires immediate treatment. The higher prevalence of PRAKI in developing countries (4–26%) versus wealthy nations (1.0–2.8%) has considerably indicated the impact of socioeconomic status and the accessibility of health services.

23 November 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ACArzou B. Chalil
Arzou B. Chalil
EAEmmanouil Andreou
Emmanouil Andreou
PPParaskevas Perros
Paraskevas Perros
ISIOAKEIM SAPANTZOGLOU
IOAKEIM SAPANTZOGLOU
AKAntonios Koutras
Antonios Koutras
EKEmmanuel Kontomanolis
Emmanuel Kontomanolis
Background: Preeclampsia (PE) is a multicomplex disorder occurring during pregnancy, characterized by the onset of hypertension and proteinuria, or hypertension accompanied by organ dysfunction (such as impaired liver function, renal insufficiency, pulmonary edema, or cerebral and visual impairment), with or without proteinuria in the latter half of pregnancy or postpartum. It impacts around 5% of all pregnancies, resulting in considerable fetal and maternal mortality and morbidity. A properly regulated inflammatory response is crucial for achieving a successful pregnancy; nevertheless, an excessive reaction appears to contribute to the onset of this syndrome. This review sought to investigate the role and correlation of interleukins (IL)-15, IL-16, IL-17, and IL-35 in the pathogenesis of PE, along with the prospective application of biomarkers in predicting and monitoring this illness. Methods: A thorough investigation was performed in the PubMed/Medline, Scopus, and Google Scholar electronic databases up to September 2025, employing the terms PE, Pregnancy, IL-15, IL-16, IL-17, IL-35, Inflammatory Response, and Cytokines. Women at the time of diagnosis were matched with normotensive counterparts of similar gestational age. Results: A total of 30 full-text articles were obtained following a thorough assessment. The majority of the published data showed that women with preeclampsia have significantly higher levels of IL-15 and IL-17 in their plasma compared to normotensive women, whereas IL-35 levels were mainly decreased, respectively. Moreover, IL-16 levels were elevated across all the studies, primarily correlating with condition severity. Conclusions: Collectively, IL-15, IL-16, IL-17, and IL-35 are markedly linked to the immunopathology of preeclampsia, with elevated maternal serum levels corresponding with the presence and severity of the disease. These cytokines demonstrate potential as biomarkers for diagnosis, prognosis, and disease surveillance. Future study, including the examination of cytokine profiles in placental and amniotic fluid, as well as additional intriguing cytokines, is essential to clarify their prognostic importance and mechanistic roles.

8 January 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EAEmmanouil Andreou
Emmanouil Andreou
Charalampos KarachaliosCharalampos Karachalios
Charalampos Karachalios
PPParaskevas Perros
Paraskevas Perros
ILIlias Liapis
Ilias Liapis
GKGeorgia Koutsogeorgopoulou
Georgia Koutsogeorgopoulou
ALAntonios Lagkadas
Antonios Lagkadas
Infertility affects thousands of couples internationally, leaving a profound effect on their families and communities. According to the World Health Organization (WHO), approximately one out of six individuals of reproductive age worldwide experiences infertility in their life span. Approximately 35% of infertile couples are affected by male factor infertility, in which semen analysis is the gold standard diagnostic procedure. Oxidative stress (OS) is considered to play a pivotal role in the pathogenesis of male infertility. A thorough literature search was conducted in PubMed/MEDLINE, Scopus and Google Scholar databases, using MeSH terms and free-text keywords, to retrieve eligible articles published in the last decade, focusing on the potential beneficial role of oral antioxidants in male infertility. Antioxidant supplementation appears to improve the majority of sperm parameters. Therefore, antioxidant therapy is emerging as a promising aid in addressing male infertility. The purpose of this comprehensive literature review is to evaluate the significance of antioxidant supplementation in improving sperm parameters. Most of the included randomized controlled trials demonstrated the positive effects of oral antioxidants in various parameters, such as sperm concentration, total sperm count, motility and progressive motility. Consequently, pregnancy outcomes were evaluated, and increased pregnancy rates were reported in the majority of the included studies.